In addition, an EREG knockdown re-sensitized NSCLC cells to cisplatin and taxol, which was accompanied by the ERK1/2 dephosphorylation and the decreased expression of stemness-associated genes. This evidence concerns the gene MAPK3 and non-small cell lung carcinoma.